Calcium phosphate cements loaded with basic fibroblast growth factor: Delivery and in vitro cell response

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 4, 2013, Pages 923-931

  Perez, Roman A ^a,b,c   Kim, Tae Hyun ^c   Kim, Meeju ^c,d   Jang, Jun Hyeog ^e   Ginebra, Maria Pau ^a,b   Kim, Hae Won ^c,d,f  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c BK21 Plus NBM Global Research Center for Regenerative Medicine   (South Korea)

^d Dankook University   (South Korea)

^e Inha University School of Medicine   (South Korea)

^f Dankook University   (South Korea)

Author keywords

Bone regeneration; Calcium phosphate cements; Cell proliferation; Growth factor delivery; Powder size

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL PROPERTIES; BONE REGENERATION; BONE TISSUE ENGINEERING; CALCIUM PHOSPHATE CEMENT; GROWTH FACTOR DELIVERY; POWDER SIZE; TRICALCIUM PHOSPHATE CEMENT;

CEMENTS; OSTEOBLASTS; STEM CELLS; TISSUE ENGINEERING;

CELL PROLIFERATION;

BONE CEMENT; CALCIUM PHOSPHATE CEMENT; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; BONE REGENERATION; CELL ASSAY; CELL PROLIFERATION; CELL STRUCTURE; IN VITRO STUDY; OSTEOBLAST; PARTICLE SIZE; PHYSICAL CHEMISTRY; TISSUE ENGINEERING;

ANIMALS; BONE CEMENTS; CALCIUM PHOSPHATES; CELL LINE; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMOBILIZED PROTEINS; MATERIALS TESTING; MICE; OSTEOBLASTS; POROSITY;

EID: 84876175281     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34390     Document Type: Article

References (21)

1. Dorozhkin SV. Calcium orthophosphate cements for biomedical application. J Mater Sci 2008;43:3028-3057.
2. Engel E, del Valle S, Aparicio C, Altankov G, Asin L, Planell JA, Ginebra MP. Discerning the role of topography and ion exchange in cell response of bioactive tissue engineering scaffolds. Tissue Eng 2008;14:1341-1351.
3. Perez RA, Ginebra MP, Spector M. Cell response to collagen-calcium phosphate cement scaffolds investigated for nonviral gene delivery. J Mater Sci Mater Med 2011;22:887-897.
4. Hempel U, Reinstorf A, Poppe M, Fischer U, Gelinsky M, Pompe W, Wenzel KW. Proliferation and differentiation of osteoblasts on Biocement D modified with collagen type I and citric acid. J Biomed Mater Res B Appl Biomater 2004;71:130-143.
5. Perez RA, Kim HW, Ginebra MP. Polymeric additives to enhance the functional properties of calcium phosphate cements. J Tissue Eng 2012;3:2041731412439555.
6. Ginebra MP, Traykova T, Planell JA. Calcium phosphate cements: Competitive drug carriers for the musculoskeletal system? Biomaterials 2006;27:2171-2177.
7. Espanol M, Perez RA, Montufar EB, Marichal C, Sacco A, Ginebra MP. Intrinsic porosity of calcium phosphate cements and its significance for drug delivery and tissue engineering applications. Acta Biomater 2009;5:2752-2762.
8. Yun YR, Won JE, Jeon E, Lee S, Kang W, Jo H, Jang JH, Shin US, Kim HW. Fibroblast growth factors: biology, function and application for tissue regeneration. J Tissue Eng 2010;2010: 218142.
9. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986;83:7297-7301.
10. Lisignoli G, Zini N, Remiddi G. Basic firbroblast growth factor enhances in vitro mineralization of rat bone marrow stromal cells grown on non-woven hyaluronic acid based polymer scaffolds. Biomaterials 2001;22:2095-2105.
11. Hong KS, Kim EC, Bang SH, Chung CH, Lee YI, Hyun JK, Lee HH, Jang JH, Kim TI, Kim HW. Bone regeneration by bioactive hybrid membrane containing FGF2 within rat calvarium. J Biomed Mater Res A 2010;94:1187-1194.
12. Maehara H, Sotome T, Yoshii T. Repair of large osteochondral defects in rabbits using porous hydroxyapatite/collagen (HAp/Col) and fibroblast growth factor-2 (FGF-2). J Orthop Res 2010;28: 677-686.
13. Jang JH, Ku Y, Chung C-P, Heo S-J. Enhanced fibronectin-mediated cell adhesion of human osteoblast by fibroblast growth factor, FGF-2. Biotechnol Lett 2002;24:1659-1663.
14. Perez RA, Del Valle S, Altankov G, Ginebra MP. Porous hydroxyapatite and gelatin/hydroxyapatite microspheres obtained by calcium phosphate cement emulsion. J Biomed Mater Res B Appl Biomater 2011;97:156-166.
15. Perez RA, Altankov G, Jorge-Herrero E, Ginebra MP. Micro- and nanostructured hydroxyapatite-collaen microcarriers for bone tissue-engineering applications. J Tissue Eng Regen Med 2012. DOI: 10.1002/term.530.
16. Stahli C, Bohner M, Bashoor-Zadeh M, Doebelin N, Baroud G. Aqueous impregnation of porous β-tricalcium phosphate scaffolds. Acta Biomater 2010;6:2760-2772.
17. Zhou H, Wu T, Dong X, Wang Q, Shen J. Adsorption mechanism of BMP-7 on hydroxyapatite (001) surfaces. Biochem Biophys Res Commun 2007;361:91-96.
18. Kilpadi KL, Chang PL, Bellis SL. Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res 2001;57:258-267.
19. Nihouannen DL, Hacking SA, Gbureck U, Komorova SV, Barralet JE. The use of RANKL-coated brushite cement to stimulate bone remodelling. Biomaterials 2008;29:3253-3259.
20. Niedhart C, Maus U, Miltner O, Gräber HG, Niethard FU, Siebert CH. The effect of basic fibroblast growth factor on bone regeneration when released from a novel in situ setting tricalcium phosphate cement. J Biomed Mater Res A 2004;69:680-685.
21. Miller ED, Fisher GW, Weiss LE, Walker LM, Campbell PG. Dosedependent cell growth in response to concentration modulated patterns of FGF-2 printed on fibrin. Biomaterials 2006;27: 2213-2221.